Division News

School of Medicine is Third in Nation for Federal Medical Research Funding

Duke University School of Medicine was awarded more than $608 million in federal funding from the National Institutes of Health (NIH) in 2021, ranking third nationally among academic medical centers, up from 10th last year, according to the Blue Ridge Institute for Medical Research.

The Department of Medicine's award of that total was $174,530,472. 

New Funding Awards - November 2021

Sponsored Research

Andrew Armstrong of Medical Oncology has received an award from the Movember Foundation for a project entitled "International Retrospective Collaborative Analysis of the Impact of Ablative Therapy Directed to the Local Tumor and/or Metastases for Patients with Oligometastatic Prostate Cancer¿." TBD

Vance Fowler of Infectious Diseases has received an award from the National Institutes of Health for a project entitled "HLA Fine Mapping to Elucidate S. aureus Susceptibility - R01." Total funding will be $3,757,863.

Inaugural Vice Chiefs for Diversity, Equity, and Inclusion (VCDEI) announced

The Diversity, Equity, Inclusion, and Anti-Racism Committee (DEIAR) announced the individuals selected to become the inaugural Vice Chiefs for Diversity, Equity, and Inclusion (VCDEI) for each division within the department of medicine. These individuals are all wonderful thoughtful leaders who have shown a commitment to improving DEI within the department.

New Funding Awards - August 2021

Sponsored Research 

Jatin Roper of Gastroenterology has received an award from the National Institutes of Health for a project entitled "Ultra-bright fluorescent nanoparticles for colorectal adenoma detection." Total funding will be $461,090.

New funding awards - July 2021

Sponsored Research

Sudha Shenoy of Cardiology has received an award from the National Institutes of Health for a project entitled "Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart." Total funding will be $2,248,260.

Pamela Douglas of Cardiology has received a sub-award through the Massachusetts General Hospital for a project entitled "Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)." Total funding will be $152,536.

New Faculty: July 2021

A warm welcome to new Department of Medicine faculty members who started in July 2021!

Pearls from 7/13/21 LEADS

The July 13, 2021 session of Duke Medicine LEADS featured a discussion led by Geargin Wilson, MD, "ANTI vs. PROcalcitonin: A discussion on the utility of Procalcitonin."

Panelist included, Stephen Bergin, MD, and Ephraim Tsalik, MD, PhD, who weighed in for the diagnostic reasoning discussion.